| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63323-762-10 | 63323-762 | HUMAN PRESCRIPTION DRUG | Topotecan Hydrochloride | TOPOTECAN HYDROCHLORIDE | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20101130 | N/A | ANDA | ANDA091089 | Fresenius Kabi USA, LLC | TOPOTECAN HYDROCHLORIDE | 4 mg/4mL | 1 VIAL in 1 BOX (63323-762-10) / 4 mL in 1 VIAL |
| 63323-762-94 | 63323-762 | HUMAN PRESCRIPTION DRUG | Topotecan Hydrochloride | TOPOTECAN HYDROCHLORIDE | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20101130 | N/A | ANDA | ANDA091089 | Fresenius Kabi USA, LLC | TOPOTECAN HYDROCHLORIDE | 4 mg/4mL | 1 VIAL in 1 BOX (63323-762-94) / 4 mL in 1 VIAL |